Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Praxis Precision Medicines Inc (PRAX)

Praxis Precision Medicines Inc (PRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Praxis Precision Medicines Receives FDA Rare Pediatric Disease Designation for Relutrigine in Dravet Syndrome Quiver Quantitative, Inc. - Wed Dec 18, 2024

Praxis receives FDA designation for relutrigine in Dravet syndrome, plans all-DEE trial, emphasizing commitment to rare neurological disorders.Quiver AI SummaryPraxis Precision Medicines, Inc. has announced...

PRAX : 80.93 (+1.77%)
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome GlobeNewswire - Wed Dec 18, 2024

PRAX : 80.93 (+1.77%)
Praxis Precision Medicines to Present at Upcoming December Investor Conferences GlobeNewswire - Tue Dec 3, 2024

PRAX : 80.93 (+1.77%)
Praxis Precision Medicines to Showcase Updates from Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting GlobeNewswire - Tue Nov 26, 2024

PRAX : 80.93 (+1.77%)
Praxis Precision Medicines to Participate in Three Upcoming November Investor Conferences GlobeNewswire - Wed Nov 6, 2024

PRAX : 80.93 (+1.77%)
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Wed Nov 6, 2024

PRAX : 80.93 (+1.77%)
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 GlobeNewswire - Fri Nov 1, 2024

PRAX : 80.93 (+1.77%)
Wall Street - shutterstock_253136563
Stocks Give Up Early Gains as Nvidia Weighs on Chip Stocks Barchart - Tue Mar 26, 2024

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.36%. Stock indexes...

$SPX : 5,942.47 (+1.26%)
SPY : 591.95 (+1.25%)
$DOWI : 42,732.13 (+0.80%)
DIA : 427.16 (+0.79%)
$IUXX : 21,326.16 (+1.67%)
QQQ : 518.58 (+1.64%)
ZNH25 : 108-205s (-0.16%)
UPS : 123.79 (-0.06%)
IP : 52.85 (-0.58%)
MMM : 129.87 (+0.13%)
NVDA : 144.47 (+4.45%)
GFS : 43.18 (+1.65%)
Invitae's Real-World Ciitizen Data Utilized in Praxis Precision Medicines' PRAX-222 IND Filing PR Newswire - Tue Sep 20, 2022

/PRNewswire/ -- Invitae (NYSE: NVTA) and Praxis Precision Medicines, Inc. (NASDAQ: PRAX), today announced that real-world clinical insights from Invitae's...

NVTA : 0.0195 (+2.63%)
IONS : 34.81 (+0.35%)
PRAX : 80.93 (+1.77%)
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2022 Financial Results Globe Newswire - Mon Aug 8, 2022

PRAX-944 Phase 2b Essential1 Study topline results expected in 4Q22; primary endpoint updated to efficacy PRAX-562 Phase 1 study completed, confirming...

PRAX : 80.93 (+1.77%)

Barchart Exclusives

Confused About Carvana (CVNA)? Try an Overlooked Long Iron Condor Trade. Barchart - Sat Jan 4, 9:15AM CST
After a blistering run from single-digit territory in late 2022, CVNA stock appears to have finally met its match. Here’s how to play the game moving forward. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot